The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has signed a memorandum of understanding with the Quantitative Medical Imaging Coalition (QMIC), setting up a long-term collaboration to standardize quantitative PET and SPECT imaging in multicenter clinical trials and routine practice.
Areas of focus include the following:
- Harmonized guidelines for PET/CT and SPECT/CT image acquisition, documentation, processing, and analysis
- Development, validation, and clinical implementation of quantitative PET/CT and SPECT/CT imaging biomarkers
- A network of PET/CT and SPECT/CT scanners and clinical sites that meet harmonized quantitative imaging requirements, supported by standardized scanner validation and calibration
- Standards for quantifying total tumor volume on prostate-specific membrane antigen (PSMA) PET and metabolic tumor volume on FDG-PET, along with related biomarkers for other radiotracers
The work will combine SNMMI’s experience in scanner validation, calibration, and quantitative image acquisition with QMIC’s work on imaging biomarkers and standardized image analysis, the organizations said. It will also include continued refinement of quantitative PET/CT guidelines through QMIC’s biomarker committees, including its tau PET and FDG-PET/CT committees.
